The Exchange had sought clarification from Rail Vikas Nigam Limited with respect to announcement dated 20-10-2022 regarding Bagging orders/contract.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:Awarding of order(s)/contract(s)1. Whether order(s) / contract(s) is awarded to domestic/ international entity2. Significant terms and conditions of order(s)/contract(s) awarded, in brief;3. Time period, if any, associated with the order(s)/contract(s);4. Broad commercial consideration or size of the order(s)/contract(s);5. Whether the promoter/ promoter group/group companies have any interest in that entity to whom the order(s)/contract(s) is awarded? If Yes, nature of interest and details thereof;6. Whether the same would fall within related party transactions? If yes, whether the same is done at ?arms length?.The response of the company is attached.
Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 27-Oct-2022 titled Alembic Pharmaceuticals receives USFDA Final Approval for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) Multiple-Dose Vials.
Tata Chemicals Limited has informed the Exchange about Investor Presentation
Themis Medicare Limited has informed the Exchange about Upgrade of Credit Rating
Cyient Limited has informed the Exchange about press release dated 27-Oct-2022 titled Press Release
Lloyds Steels Industries Limited has informed the Exchange about Board Meeting held on 27-Oct-2022 to consider financial statements for the period ended September 2022 and Other business matters
Sigachi Industries Limited has informed the Exchange about Earnings Presentation on Q2 FY23 Results
VIP Industries Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Nov-2022.
Oil Country Tubular Limited has informed the Exchange about Board Meeting held on 27-Oct-2022 to consider financial statements for the period ended September 2022
Premier Explosives Limited has informed the Exchange about Investor Presentation
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
